Journal of Urology

Papers
(The TQCC of Journal of Urology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Urological Oncology: Bladder, Penis and Urethral Cancer, and Basic Principles of Oncology418
Urological Oncology: Prostate Cancer358
Editorial Comment324
This Month in Adult Urology307
Urological Oncology: Testis Cancer and Advances in Oncologic Therapy292
MP06-15 VIRTUAL REALITY IMMERSION FOR REDUCING ANXIETY AND PAIN DURING TRANSPERINEAL PROSTATE BIOPSY: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL264
MP27-09 OXYMATRINE IMPROVES ERECTILE FUNCTION THROUGH SUPPRESSION OF INFLAMMATION AND FIBROSIS IN DIABETIC RATS225
MP17-14 IDENTIFYING CRIBRIFORM PATTERN IN MPMRI SCANS FROM 3D RECONSTRUCTED RALP SPECIMENS USING DEEP LEARNING180
MP40-03 CIRCULATING CHROMOSOME CONFORMATION SIGNATURES ENHANCE THE ACCURACY OF PSA FOR DETECTING PROSTATE CANCER - RESULTS FROM PERFORMANCE OF THE EPISWITCH TM PCA T158
MP22-04 MAINTENANCE OF SKELETAL MUSCLES WHEN RECEIVING NEOADJUVANT CHEMOTHERAPY IMPROVES THE PROGNOSIS FOR PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER152
PD33-08 BACTERIAL BIOFILMS FROM INDWELLING SACRAL NEUROMODULATION DEVICES ARE RECONSTITUTABLE IN VITRO AND EXHIBIT DIFFERENTIAL FORMATION BY MATERIAL TYPE150
V02-10 LIMITED RESOURCES IMPROVISED BASKETS FOR PCNL139
MP67-12 FIRST LOOK: LASER SPECKLE IMAGING IS A NOVEL METHOD TO IDENTIFY AND PRESERVE NEUROVASCULAR BUNDLE DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY130
PD23-04 URINARY PROTEINS IN THE DIAGNOSIS OF MIXED INTRINSIC SPHINCTER DEFICIENCY AND DETRUSOR OVERACTIVITY IN FEMALE PATIENTS WITH STRESS URINARY INCONTINENCE?126
PD32-07 RACE MODIFIED ESTIMATED GLOMERULAR FILTRATION RATE UNDERESTIMATES CHRONIC KIDNEY DISEASE PREVALENCE IN AFRICAN-AMERICAN PATIENTS UNDERGOING PARTIAL AND RADICAL NEPHRECTOMY: IMPLICATIONS FOR SU105
MP64-20 UNDERSTANDING CLINICAL OUTCOMES IN PATIENTS RENDERED NO EVIDENCE OF DISEASE IN METASTATIC RENAL CELL CARCINOMA102
PD12-11 URETHRAL COMPLICATIONS AFTER METOIDIOPLASTY WITH URETHRAL RECONSTRUCTION90
PD27-02  99m TC-PSMA RADIOGUIDED SURGERY USING A DROP-IN GAMMA PROBE IN RADICAL PROSTATECTOMY: INITIAL RESULTS80
PD08-12 PREDICTORS OF PROGRESSION AND DELAYED INTERVENTION IN SMALL RENAL MASS PATIENTS UNDERGOING ACTIVE SURVEILLANCE WITHOUT HEALTH-RELATED SELECTION BIAS75
V04-06 ROBOTIC ASSISTED TRANS-VESICOSCOPIC URETERIC REIMPLANTATION IN CHILDREN: SURGICAL ERGONOMICS RELATED TO MUSCULOSKELETAL SYMPTOMS74
MP53-20 INITIAL UROLOGIC EVALUATION FOR ANORECTAL MALFORMATIONS: A PCPLC RETROSPECTIVE71
MP28-03 CYTOREDUCTIVE NEPHRECTOMY FOLLOWING IMMUNE CHECKPOINT INHIBITORS IS SAFE AND FACILITATES TREATMENT FREE INTERVALS69
V07-07 WIRE-GUIDED EXTRAVESICAL ROBOT-ASSISTED BLADDER DIVERTICULECTOMY AND Y-V PLASTY FOR RECURRENT BLADDER NECK STRICTURE67
LBA01-08 EFFICACY OF TARGETED MAST CELL INHIBITION THERAPY IN CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME65
PD04-08 BALIXAFORTIDE, A CXCR4 INHIBITOR, SYNERGIZES WITH DOCETAXEL TO DIMINISH TUMOR GROWTH IN A PROSTATE CANCER MODEL OF BONE METASTASIS65
PD43-02 FUNCTIONAL OUTCOMES AFTER SELECTIVE CLAMPING IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY64
MP48-04 PERSPECTIVES OF SOCIETY OF WOMEN IN UROLOGY MEMBERS TOWARD DOBBS V. JACKSON WOMEN′S HEALTH ORGANIZATION63
MP38-19 FOCAL THERAPY CANDIDACY: AN EVALUATION OF INITIAL AND CONTINUED ELIGIBILITY FOR FOCAL THERAPY IN AN ACTIVE SURVEILLANCE COHORT62
MP66-14 WEBSITE TRANSPARENCY AND INFORMATION DISSEMINATION AMONG UROLOGY RESIDENCY PROGRAMS61
PD17-03 REDOX IMBALANCE AND MAPK ACTIVATION MEDIATES PNEUMOPERITONEUM-INDUCED KIDNEY INJURY DURING MINIMALLY INVASIVE SURGERY52
PD39-07 CAN WE STOP DOING SYSTEMATIC BIOPSIES IN MEN WITH PIRADS/LIKERT 5 LESIONS ON MULTI PARAMETRIC MAGNETIC RESONANCE IMAGING? AN ANALYSIS FROM A MULTICENTRE PROSPECTIVE DATASET OF OVER 800 PATIENT52
MP57-02 AN UPDATE ON PROFESSIONAL BURNOUT AND CONFLICT-WORK FROM THE AUA WORKFORCE WORKGROUP48
HF02-04 KEEPING IT REEL: PHOTOGRAPHY AND CINEMATOGRAPHY IN UROLOGY46
MP12-03 IMPLICATIONS OF RACE FREE RENAL FUNCTION EQUATIONS ON BLACK PATIENTS WITH RENAL CELL CARCINOMA44
PD24-03 BEST TREATMENT FOR OLIGOMETASTATIC RENAL CANCER: A QUASI-INDIVIDUAL PATIENT DATA ANALYSIS44
MP30-02 A NOVEL PREDICTION MODEL FOR POSSIBILITY OF SPERM RETRIEVAL IN MICRO TESE FOR NON-OBSTRUCTIVE AZOOSPERMIA PATIENTS USING AUTOMATED ARTIFICIAL INTELLIGENCE42
MP70-07 HIGH-PERFORMING SCALABLE EXTRACTION OF ELEMENTS OF URINARY TRACT DILATION CLASSIFICATION USING NATURAL LANGUAGE PROCESSING ALGORITHMS FOR NEONATAL ULTRASOUND REPORTS41
MP62-05 AUA RECOMMENDED ANTIBIOTIC PROPHYLAXIS FOR PRIMARY PENILE IMPLANTATION RESULTS IN A HIGHER, NOT LOWER, RISK FOR POST-OPERATIVE INFECTION: A MULTICENTER ANALYSIS41
MP36-05 CLINIC SCORE - A NOVEL PREDICTION MODEL OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM OUTCOMES IN MEN WITH PEYRONIE’S DISEASE41
PD19-09 IMMUNOPROPHYLAXIS WITH AUTOVACCINE DECREASES HOSPITAL ADMISSIONS AND EMERGENCY ROOM VISITS IN PATIENTS WITH NEUROGENIC BLADDER40
MP36-04 PREDICTORS OF PENILE PLICATION AFTER INTRALESIONAL COLLAGENASE CLOSTRIDIUM HISTOLYTICUM INJECTION IN MEN WITH PEYRONIE’S DISEASE40
MP02-03 FASCIOCUTANEOUS FLAP CLOSURE OF THE PERINEUM AS AN ALTERNATIVE TO SCROTOPLASTY FOR EXTENSIVE GENITAL TISSUE LOSS39
PD14-12 SEXUAL FUNCTION IN WOMEN FOLLOWING TENSION-FREE VAGINAL TAPE-OBTURATOR PROCEDURE: A PROSPECTIVE STUDY39
MP41-18 CLINICAL MANIFESTATIONS OF BIRT-HOGG-DUBE SYNDROME IN A LARGE CLINICAL COHORT37
PD31-09 DEVELOPMENT OF EXTREME GRADIENT BOOST (XGBOOST) MACHINE LEARNING MODEL USING AN INSTITUTIONAL PEDIATRIC KIDNEY TRANSPLANT DATABASE FOR PREDICTION OF DELAYED GRAFT FUNCTION36
PD47-12 DOES ANESTHESIA TYPE MATTER IN SHOCKWAVE LITHOTRIPSY?35
PD51-08 SREBP1 INDUCES RESISTANCE TO HIF-2α ANTAGONIST IN CLEAR CELL RENAL CELL CARCINOMA35
MP38-07 UPGRADING ON PER PROTOCOL VS FOR CAUSE SURVEILLANCE PROSTATE BIOPSIES: AN OPPORTUNITY TO DECREASING THE BURDEN OF ACTIVE SURVEILLANCE35
MP33-08 OPIOID PRESCRIBING PATTERNS AND POST-PROSTATECTOMY READMISSION35
MP15-18 MOLECULAR CHARACTERIZATION OF URETHRAL CANCER AND COMPARISON WITH BLADDER CANCER34
PD35-04 OPEN VS. ROBOTIC-ASSISTED RECONSTRUCTION IN VESICOURETHRAL ANASTOMOTIC STENOSIS33
Reply by Authors33
Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology33
V02-06 A TECHNIQUE FOR COMBINED ROBOTIC SACROCOLPOPEXY AND VENTRAL MESH RECTOPEXY33
Editorial Comment33
MP57-13 IS BIPOLAR ENUCLEATION OF THE PROSTATE AN EFFECTIVE AND COST-EFFICIENT ALTERNATIVE TO ROBOTIC SIMPLE PROSTATECTOMY?33
MP02-18 APPROPRIATENESS OF IMAGING FOR LOW-RISK PROSTATE CANCER – REAL WORLD DATA FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATION (PURC)32
MP01-10 THE LANDSCAPE OF RACIAL AND ETHNIC DISPARITY IN TESTICULAR CANCER STAGE PRESENTATION: A NATIONAL HOSPITAL-BASED STUDY30
PD58-09 GROWTH KINETICS OF ONCOCYTIC NEOPLASMS ON ACTIVE SURVEILLANCE AND IMPACT ON RENAL FUNCTION29
MP62-13 LONG-TERM MEDICATION USE AFTER SURGICAL TREATMENT FOR BLADDER OUTLET OBSTRUCTION, HOW DOES HOLEP COMPARE TO OTHER SURGICAL MODALITIES?29
PD61-05 ONCOLOGICAL OUTCOMES OF NEOADJUVANT DEGARELIX WITH APALUTAMIDE (ARNEO TRIAL) VERSUS STANDARD OF CARE PRIOR TO RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A PROPENSITY SCORE MATCHED AN29
MP76-14 PROPHYLACTIC DIPS AND IRRIGATION SOLUTIONS CAN CONSIDERABLY ALTER THE ANTIMICROBIAL EFFICACY OF INFLATABLE PENILE PROSTHESIS HYDROPHILIC SURFACE COATINGS29
PD23-09 THE EFFECT OF ADRENALECTOMY ON OVERALL SURVIVAL IN METASTATIC ADRENOCORTICAL CARCINOMA29
PD47-07 THE STUDY OF AUTOMATIC RECOGNITION OF STONE COMPONENTS USING DIGITAL IMAGES FROM INTRAOPERATIVE FLEXIBLE URETEROSCOPY29
MP24-16 URETEROSCOPY AT AMBULATORY SURGERY CENTERS CAN BE SAFE FOR CAREFULLY SELECTED HIGH-RISK PATIENTS29
MP32-17 LONG-TERM FOLLOW-UP AND SUCCESS RATE OF VENTRAL INLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY VS DORSAL ONLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY FOR FEMALE URETHRAL STRICTURE DISEASE28
MP02-01 "DOCTOR 1 PUT ME IN TOUCH WITH A FORMER PATIENT... OF MY EXPERIENCE THROUGH IT, I THINK SHE HELPED ME THE MOST": PEER SUPPORT AS AN INVALUABLE RESOURCE IN THE SETTING OF BLADDER CANCER SURGERY28
PD14-08 IDENTIFICATION OF A BLADDER CANCER SUBPOPULATION THAT MAY BENEFIT FROM DASATINIB27
MP34-14 ASSOCIATION OF POPULATION-LEVEL SOCIAL DETERMINANTS OF HEALTH WITH UROLOGIC CANCER CLINICAL TRIALS AVAILABILITY27
MP31-07 PROSTATE EXTRACELLULAR VESICLES AND PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A PROSPECTIVE SINGLE-INSTITUTION PILOT STUDY27
MP08-20 SIGNIFICANT DROP OF EARLY AND TWO-YR MORTALITY FOR BLADDER CANCER PATIENTS RECEIVING RADICAL CYSTECTOMY IN THE LAST 20 YEARS: SINGLE CENTER ANALYSIS27
PD55-09 THE BALL IS OUT OF OUR COURT: DOES MODERN PRIMARY CARE LITERATURE REFLECT THE AMERICAN UROLOGICAL ASSOCIATION CRYPTORCHIDISM GUIDELINES?26
MP76-02 EXPLORING THE EFFECTS OF AMNIOTIC BLADDER THERAPY ON FEMALE SEXUAL DYSFUNCTION IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME PATIENTS26
MP21-06 USABILITY TESTING OF THE SET BRAVE GOALS APP, A CONTINENCE GOAL-SELECTION APP FOR CHILDREN WITH SPINA BIFIDA26
MP35-13 PREVALENCE, TRENDS, AND COSTS OF OFFICE-BASED AND AMBULATORY SURGERY CENTER-BASED DIAGNOSTIC CYSTOSCOPY IN THE UNITED STATES26
MP03-13 ARTIFICIAL URETHRAL SPHINCTER PRESSURE REGULATING BALLOON AND CUFF VARIATIONS FOLLOWING DEVICE EXPLANTATION26
PD28-11 O TO ZZZ's: INVESTIGATING THE RELATIONSHIP BETWEEN ORGASM AND SLEEP QUALITY IN WOMEN25
MP70-20 MORTALITY DISPARITIES AMONG ASIAN AMERICANS DIAGNOSED WITH UROLOGIC CANCER25
MP44-05 PARENCHYMAL VOLUME ANALYSIS TO ASSESS LONGITUDINAL FUNCTIONAL DECLINE AND ATROPHY AFTER PN25
V11-11 HUGO RAS SIMPLE PROSTATECTOMY SEC. MILLIN: STEP BY STEP SURGICAL PROCEDURE AND SET UP IN A THREE ARMS CONFIGURATION25
PD61-12 SAME-DAY DISCHARGE FOLLOWING ROBOTIC PROSTATECTOMY: STANDARDIZATION AND SAFETY EVALUATION25
PD49-07 UTILITY OF TESTICULAR SHEAR-WAVE ELASTOGRAPHY IN THE EVALUATION OF PEDIATRIC PATIENTS WITH KLINEFELTER SYNDROME25
MP36-11 GERIATRIC NUTRITIONAL RISK INDEX AS A SIGNIFICANT PROGNOSTIC FACTOR IN PATIENTS WITH CLEAR-CELL RENAL CELL CARCINOMA25
MP63-07 THE BUTOX STUDY: THE ROLE OF THE GUT MICROBIOME AND BUTYRATE IN CALCIUM OXALATE KIDNEY STONE DISEASE25
PD27-01 DEVELOPMENT OF A MACHINE LEARNING (ML) MODEL TO AUTOMATICALLY AND PRECISELY IDENTIFY KIDNEY STONES FROM URETEROSCOPY VIDEO RECORDINGS24
MP19-05 LEARNING CURVES OF FUSION-GUIDED BIOPSY AND ULTRASOUND PROSTATE SEGMENTATION: A SINGLE-CENTER STUDY INVOLVING 14 OPERATORS AND 1721 PATIENTS24
PD31-06 LONG-TERM OUTCOMES AFTER ISOLATED EPISPADIAS REPAIR24
PD28-08 ASSOCIATION OF LOW TESTOSTERONE, FRAILTY, AND POSTOPERATIVE OUTCOMES AMONG MEN UNDERGOING UROLOGIC SURGERY24
MP43-19 NOVEL NANOPARTICLE COATINGS DEMONSTRATE ANTIBACTERIAL AND ANTIBIOFILM PROPERTIES AGAINST MULTIPLE UROPATHOGENS23
PD52-01 A PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER TRIAL TO EVALUATE SAFETY AND EFFICACY OF PLATELET-RICH PLASMA INJECTIONS FOR PEYRONIE'S DISEASE: CLINICAL TRIAL UPDATE23
MP69-07 UROLOGIC COMPLICATIONS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 (SGLT-2) INHIBITORS DIFFER BETWEEN DIABETIC MEN AND WOMEN22
MP54-17 FOSTERING DIVERSITY IN UROLOGY: ADDRESSING ETHNIC DISPARITIES IN APPLICANT AND RESIDENT RECRUITMENT22
PD33-09 PATHOLOGIC DOWN STAGING WITH NEOADJUVANT CHEMOTHERAPY AS A PREDICTOR OF ONCOLOGICAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY: A ROBUUST REGISTRY ANALYSIS22
PD14-10 ENHANCED ANTITUMOR EFFECT OF THE COMBINATION OF BACILLE CALMETTE-GUÉRIN AND AN IMMUNE CHECKPOINT INHIBITOR IN BLADDER CANCER-ON-A-CHIP22
MP69-05 DEVELOPING AN ANTIMICROBIAL IRRIGATION SOLUTION FOR ENDOUROLOGICAL PROCEDURES: EX VIVO EFFICACY AND IN VIVO SAFETY22
MP09-01 TEMPORAL TRENDS OF BPH MEDICATIONS AND PROCEDURES - CONTEMPORARY MEDICARE DATABASE ANALYSIS FROM 2013-202022
MP26-04 HOW MIRABEGRON AFFECTS THE HUMAN URETER: AN IN VITRO STUDY22
PD33-10 ROBOT-ASSISTED PARTIAL NEPHRECTOMY WITH HUGO™ RAS SYSTEM: PERIOPERATIVE OUTCOMES AND TRIFECTA ACHIEVEMENT FROM THE LARGEST MULTICENTRIC SERIES21
PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS OF TREATMENT SEQUENCE21
MP29-20 A PROSPECTIVE, SINGLE CENTER RANDOMISED CONTROLLED TRIAL COMPARING DUSTING AND FRAGMENTATION MODES OF THULIUM FIBER LASER IN RETROGRADE INTRARENAL SURGERY21
MP36-19 DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA21
MP39-14 EVALUATING THE CONTRIBUTION OF THE STANDARDIZED LETTER OF RECOMMENDATION TO A SUCCESSFUL MATCH IN UROLOGY RESIDENCY21
PD55-04 IS PERCUTANEOUS NEPHROLITHOTOMY EFFECTIVE AND SAFE IN INFANTS YOUNGER THAN 2 YEARS OLD? COMPARISON OF MINI AND STANDARD PERCUTANEOUS NEPHROLITHOTOMY?21
PD14-05 THE STROMA-RICH CONSENSUS BLADDER CANCER SUBTYPE CORRELATES WITH IMPROVED PROGNOSIS AFTER NEOADJUVANT IMMUNOTHERAPY AND RADICAL CYSTECTOMY21
PD18-09 THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY IN CONTEMPORARY METASTATIC RENAL CELL CARCINOMA: AN OTHER-CAUSE MORTALITY MATCH POPULATION-BASED STUDY21
MP30-15 MACHINE LEARNING TO DISTINGUISH BENIGN AND MALIGNANT RENAL LESIONS BASED ON ROUTINE CT IMAGING20
PD05-03 REDUCING EMERGENCY ROOM VISITS THROUGH THE USE OF MULTI-LANGUAGE EDUCATIONAL PAMPHLETS AFTER URETEROSCOPY WITH URETERAL STENT PLACEMENT20
MP41-11 CIRCULATING MICRORNA PROFILING FOR PREDICTION OF ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS FOLLOWING RADICAL PROSTATECTOMY20
MP18-02 DOES DEEP LEARNING RECONSTRUCTION IMPROVE URETERAL STONE DETECTION AND SUBJECTIVE IMAGE QUALITY IN THE CT IMAGES OF PATIENTS WITH METAL HARDWARE?20
V14-05 ARTIFICIAL INTELLIGENCE-BASED INTRAOPERATIVE GUIDANCE: DEMONSTRATION OF REAL-TIME SEGMENTATION AND FEATURE TRACKING IN ROBOTIC SURGERY20
MP75-17 EXAMINING THE RELATIONSHIP BETWEEN DIETARY INFLAMMATORY INDEX AND URINARY FLOW RATE: RESULTS FROM A NATIONWIDE STUDY19
V08-03 ENDOSCOPIC RESECTION OF AN ENTEROANASTOMOTIC TUMOR RECURRENCE AFTER RADICAL CYSTECTOMY: A NOVEL APPROACH USING BIPOLAR RESECTION19
MP70-06 MATCHED ANALYSIS OF URINARY TRACT INFECTIONS AND READMISSIONS AFTER OPEN URETERONEOCYSTOSTOMY: DOES AGE MATTER?19
MP47-03 TRENDS IN SBRT FOR INOPERABLE RENAL CELL CARCINOMA19
MP15-10 DISCOVERY OF TBK1 ASSOCIATED ONCOGENIC MECHANISM WHICH MEDIATES THE UPPER-TRACT UROTHELIAL CARCINOMA WITH PREEXISTING END STAGE RENAL DISEASE19
PD41-11 THE IMPACT OF PROSTATE VOLUMES (≤80 CC VS. > 80 CC) ON PERIOPERATIVE OUTCOMES AND RISK OF RETREATMENT IN PATIENTS UNDERGOING AQUABLATION: A SINGLE-CENTER STUDY19
MP79-10 PHARMACOVIGILANCE ANALYSIS OF MELANOMA ADVERSE EVENTS IN MEN TREATED WITH SILDENAFIL FOR ERECTILE DYSFUNCTION19
MP46-13 ROBOT-ASSISTED RADICAL CYSTECTOMY WITH INTRACORPOREAL PADUA ILEAL NEOBLADDER: LONG-TERM FUNCTIONAL OUTCOMES AND CONTINENCE PREDICTORS ASSESSMENT FROM A HIGH-VOLUME CENTER LARGE CONSECUTIVE SER19
PD30-07 HIGH-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER DEMONSTRATES HOMOGENEOUS ONCOLOGICAL OUTCOMES REGARDLESS OF EAU 2021 RISK GROUP STRATIFICATION19
MP49-07 DEFINING HIGH GLEASON SCORE PROSTATE CANCER BY PROSTATE FLUID METABOLIC FINGERPRINT BASED MULTI-MODAL DIAGNOSIS19
PD15-04 PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESP19
MP72-09 SELF-SCHEDULING IMPROVES QUALITY OF CARE FOR HOSPITAL DISCHARGE FOLLOW UP OF URINARY RETENTION PATIENTS19
PD08-11 ACTIVE SURVEILLANCE VERSUS PRIMARY INTERVENTION FOR CLINICAL T1a KIDNEY TUMORS: TWELVE-YEAR EXPERIENCE OF THE DISSRM PROSPECTIVE COMPARATIVE STUDY18
MP72-17 SURGEON’S PERSONAL OPIOID BEHAVIORS IMPACT POST-OPERATIVE PRESCRIBING FOR OUTPATIENT PROCEDURES18
MP44-08 RELATIONSHIP BETWEEN COVID 19 VACCINATION AND PSA LEVEL18
PD25-05 CHRONIC EXPOSURE OF PHYSIOLOGICAL CONCENTRATION OF ARSENIC INDUCED BLADDER MALIGNANCY IN PRECLINICAL MODELS18
MP35-11 TRENDS AND INCIDENCE OF REPORTED EVENTS ASSOCIATED WITH URETERAL STENTS: AN ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION'S MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE DATABASE18
MP05-01 MICRO COMPUTED TOMOGRAPHY ANALYSIS OF MINERAL IN RENAL PAPILLAE SHOWS THAT RANDALL'S PLAQUE FORMATION OCCURS INDEPENDENTLY OF UPSTREAM DUCTAL PLUGGING IN THE MEDULLA18
MP25-06 DEVELOPMENT OF A MULTI-INSTITUTIONAL, SIMULATION-BASED SURGICAL SKILLS BOOTCAMP FOR JUNIOR UROLOGY RESIDENTS18
MP61-11 RETZIUS-SPARING ROBOT-ASSISTED RADICAL PROSTATECTOMY AFTER PREVIOUS TRANS-URETHRAL RESECTION OF THE PROSTATE: ASSESSMENT OF FUNCTIONAL AND ONCOLOGICAL OUTCOMES18
MP71-18 PERIPHERAL TIBIAL NERVE STIMULATION DEMONSTRATES LIMITED IMPROVEMENT IN SELF-REPORTED SYMPTOMS FOR PATIENTS WITH OVERACTIVE BLADDER: SINGLE CENTER EXPERIENCE18
PD10-10 IMPROVING PREDICTION OF LOCAL STAGE BY PSMA-PET. DEVELOPMENT OF A NOVEL INTEGRATED TOOL FOR EXTRACAPSULAR EXTENSION AND SEMINAL VESICLE INVASION COMBINING CLINICAL AND IMAGING FEATURES IN LOCA18
PD45-03 FACTORS AFFECTING HOLMIUM LASER INEFFICIENCY: COMPARISON OF LARYNGEAL MASK AIRWAY AND ENDOTRACHEAL TUBE USE DURING FLEXIBLE URETEROSCOPY FOR RENAL STONES17
MP58-04 PROPOSAL AND INTERNAL VALIDATION OF A NOMOGRAM FOR THE PREDICTION OF LOCAL RECURRENCE FREE-SURVIVAL AFTER PERCUTANEOUS ABLATION FOR CT1 RENAL MASSES17
MP03-19 ROLE OF MICROFIBRILLAR-ASSOCIATED PROTEIN 4 IN PARTIAL BLADDER OUTFLOW OBSTRUCTION-RELATED BLADDER FIBROSIS17
MP74-18 DETRUSOR VOIDING CONTRACTION VELOCITY IS RELEVANT TO PATIENTS WITHOUT BLADDER OUTFLOW OBSTRUCTION17
MP06-20 SIGNIFICANT REDUCTION OF PERIOPERATIVE SERIOUS REPORTABLE EVENTS THROUGH A NOVEL SURGICAL SAFETY CHECKLIST AND TIME-OUT PROCEDURE17
MP75-10 SURVIVAL OUTCOMES BY RACE FOLLOWING MINIMALLY INVASIVE SURGICAL TREATMENT FOR UPPER TRACT UROTHELIAL CARCINOMA: AN ANALYSIS OF THE ROBUUST REGISTRY17
MP53-05 RISK OF ACUTE KIDNEY INJURY AFTER LOWER URINARY TRACT RECONSTRUCTION WITH EARLY NSAID THERAPY: A PROPENSITY MATCHED RETROSPECTIVE ANALYSIS17
MP15-09 TADALAFIL VERSUS COMBINED TAMSOLUSIN AND CIPROFLOXACIN FOR TREATMENT OF CHRONIC PELVIC PAIN SYNDROME: A RANDOMIZED CONTROLLED TRIAL17
LBA02-12 IS LEARNING CURVE IMPORTANT WHILE PERFORMING PSMA-PET? ANALYSIS OF DETECTION RATE ACCORDING TO GLEASON SCORE AND PSA LEVEL IN TWO TIMEFRAMES AT A BRAZILIAN HIGH-VOLUME CENTER17
PD24-07 FIRST ANALYSIS OF THE SAFETY AND EFFICACY OF UGN-101 IN THE TREATMENT OF URETERAL TUMORS17
HF02-14 HERNIAS, HEALING, HAGIOGRAPHY: AN ANALYSIS OF ST. ARTEMIOS AND BYZANTINE INCUBATION RITUALS16
Hooman Djaladat, MD, MS16
Benign Prostatic Hyperplasia: Epidemiology, Evaluation & Medical Non-surgical Therapy (MP24)16
Pro: Does COVID Affect Male Reproductive Health?16
Prostate Cancer: Markers I (MP41)16
Reply by Authors16
MP09-16 INFORMING AN APPROACH TO THE SUBCAPSULAR RENAL HEMATOMA (SRH): A TEN-YEAR REVIEW OF THE NATURAL HISTORY AND PROGRESSION OF SRH16
Bladder Cancer: Non-invasive III (MP15)16
Prostate Cancer: Detection & Screening I (MP40)15
Benign Prostatic Hyperplasia: Surgical Therapy & New Technology II (PD08)15
Health Services Research: Practice Patterns, Quality of Life and Shared Decision Making II (MP09)15
Benign Prostatic Hyperplasia: Surgical Therapy & New Technology III (IP19)15
Stone Disease: Basic Research & Pathophysiology (MP63)15
Prostate Cancer: Localized: Active Surveillance (MP38)15
Infertility: Epidemiology & Evaluation II (PD18)15
Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Non-neurogenic Voiding Dysfunction I (MP74)15
Surgical Technology & Simulation: Instrumentation & Technology (IP11)15
Bladder Cancer: Invasive VI (MP77)15
Editorial Comment15
Stone Disease: Surgical Therapy (Including ESWL) I (PD01)15
Editorial Comment14
This Month in Adult Urology14
Is Confirmatory Biopsy Still Necessary for Active Surveillance of Men With Grade Group 1 Prostate Cancer in the Era of Multiparametric MRI?14
Editorial Comment14
Male Infertility14
Editorial Comment14
IP23-07 ANATOMY OF A COMPLICATION: CLINICO-RADIOLOGIC FEATURES OF BLEEDINGS AFTER ROBOTIC-ASSISTED RADICAL PROSTATECTOMY. THE ROLE OF THE OBTURATOR ARTERY VARIANTS14
Editorial Comment14
Male and Female Sexual Function and Dysfunction; Andrology14
Reply by Authors14
Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology14
Imaging Mass Cytometry Immune Profiling of Hunner Lesions in a Convenience Sample of Patients With Interstitial Cystitis/Bladder Pain Syndrome14
PD36-05 DEEP LEARNING PREDICTIVE MODEL FOR PROSTATE CANCER RECURRENCE USING CLINICAL AND HISTOLOGICAL DATA FROM THE TCGA DATABASE14
Size Matters, at Least Sometimes…14
Editorial Comment14
Imaging14
Editorial Comment14
Editorial Comment14
Precision-guidance vs Systematic Sampling: Optimizing Biopsy Assessment of Secondary Prostate Cancer Suspicious Multiparametric Magnetic Resonance Imaging Lesions14
Urologic Heterodoxy Leads to Discovery14
MP20-07 NPTX1 IS A NOVEL SERUM BIOMARKER INDUCED BY ARPI TREATED PROSTATE CANCER AND ENRICHED IN LINEAGE PLASTICITY WITH BRN2 HIGH14
Editorial Comment14
Socioeconomic Factors, Urological Epidemiology, and Practice Patterns14
IP09-15 MANDATORY RESEARCH YEAR IN PEDIATRIC UROLOGY FELLOWSHIP TRAINING: PERCEPTIONS OF THE CURRENT WORKFORCE13
PD39-05 NEUROMODULATION OF PELVIC NERVES INCREASES NERVE REGENERATION AFTER INJURY13
Reply: Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial13
IP23-11 IMPACT OF ASPIRIN INTAKE ON BIOCHEMICAL RECURRENCE RATES IN HIGH-RISK PATIENTS FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A MULTICENTER RETROSPECTIVE COHORT STUDY13
MP15-01 SEX-BASED DIFFERENCES OF SOMATIC MUTATIONS IN CAUCASIAN BLADDER CANCER POPULATION13
PD08-01 GLOBAL AQUABLATION EXPERIENCE FROM THE ICARUS (INTERNATIONAL COLLABORATIVE AQUABLATION RESEARCH UROLOGY SOCIETY) DATABASE: LARGEST COHORT ASSESSING EFFICACY AND SAFETY IN BENIGN PROSTATIC HYPE13
IP17-31 INITIAL EXPERIENCE OF 10 CASES WITH NOVEL EXTRA-PERITONEAL MULTIPORT ROBOT-ASSISTED KIDNEY TRANSPLANT (eRAKT): A PROPENSITY-MATCHED COMPARISON WITH THE TRANSPERITONEAL APPROACH13
V15-06 SURGICAL MANAGEMENT OF TRAUMATIC INJURY IN A PEDIATRIC DUPLICATED COLLECTING SYSTEM13
Benign Prostatic Hyperplasia13
Editorial Comment13
IP27-04 PROSPECTIVE COTRIMS (COLOGNE TRIAL OF RETROPERITONEAL LYMPHADECTOMY IN METASTASTIC SEMINOMA) TRIAL – FINAL RESULTS13
PD32-10 AUTOMATED NEPHROMETRY SCORES THROUGH DIRECT PREDICTION OF EACH COMPONENT13
HF02-20 UROLOGY’S 20TH CENTURY BATTLE: SECURING ITS PLACE IN THE CLINIC AND CURRICULUM13
IP27-02 THE ROLE OF SQUAMOUS CELL CARCINOMA ANTIGEN AND INFLAMMATORY MARKERS IN THE PROGNOSIS OF PENILE SQUAMOUS CELL CARCINOMA13
MP11-02 RESULTS FROM THE CLEAR RCT SUGGEST FACTORS CORRESPONDING TO EARLY PATIENT SATISFACTION ARE BETTER FOLLOWING UROLIFT PUL VS. REZUM WVTT13
IP09-06 CLINICAL SIGNIFICANCE AND PROGNOSIS OF LOWER POLE HYDRONEPHROSIS FOLLOWING PROXIMAL URETEROURETEROSTOMY IN PEDIATRIC PATIENTS WITH DUPLEX SYSTEM13
Editorial Comment13
Letter: Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monother13
MP11-19 MEN WITH DIAGNOSED HAIR LOSS ON FIVE-ALPHA REDUCTASE INHIBITORS DO NOT HAVE DECREASED INCIDENCE OF BENIGN PROSTATIC HYPERPLASIA OR PROSTATE CANCER OVER A 20-YEAR PERIOD13
V12-03 ROBOT ASSISTED URETEROPLASTY USING VESICAL MUCOSA GRAFT: OUR INITIAL EXPERIENCE13
IP14-06 TUMOROID AND GENOMIC MODELING OF LOW GRADE INTERMEDIATE RISK BLADDER CANCER TO PREDICT INTRAVESICAL CHEMOTHERAPY RESPONSE13
PD32-11 PREOPERATIVE PREDICTORS OF ADVERSE PATHOLOGY AND RECURRENCE-FREE SURVIVAL FOR PATIENTS WITH RENAL MASSES13
PD39-09 SNM LEAD SENSING: SACRAL EVOKED RESPONSES ACROSS STANDARD THERAPY PROGRAMS12
UCF-13 ENDOUROLOGIC NEEDS ASSESSMENT TOOL: EVALUATING GLOBAL NEEDS AND BARRIERS FOR ENDOSCOPIC UROLOGICAL PROCEDURES12
MP28-10 IMPACT OF CYTOREDUCTIVE NEPHRECTOMY ON IMMUNE CHECKPOINT INHIBITOR THERAPY: TREATMENT OUTCOMES OF IMMUNE INHIBITORS COMBINATION THERAPIES FOR METASTATIC RENAL CELL CARCINOMA WITH PRIMARY KIDNE12
V02-12 PSYCHOGENIC URINARY INCONTINENCE: DA VINCI XI ROBOT-ASSISTED HEMINEPHROURETERECTOMY FOR COMPLETE DUPLEX KIDNEY WITH ECTOPIC URETERAL DRAINAGE12
PD08-10 COLLECTIVE OPTILUME BPH 2-YEAR CLINICAL OUTCOMES: COMBINED EXPERIENCE FROM THE PIVOTAL PINNACLE AND EVEREST PROSPECTIVE CLINICAL STUDIES12
MP24-08 BODY ROUNDNESS INDEX, A NOVEL OBESITY METRIC, AND ITS RELATIONSHIP WITH STRESS URINARY INCONTINENCE IN A POPULATION-BASED COHORT12
PD21-04 COMPARATIVE ANALYSIS OF LEARNING CURVES IN ENDOSCOPIC PROSTATE RESECTION AND ENUCLEATION WITH LASER DURING UROLOGY RESIDENCY: IS ENDOSCOPIC PROSTATE ENUCLEATION TRAINING EXCLUSIVE FOR EXPERTS?12
MP37-03 HIGH DEDUCTIBLE HEALTH PLAN ENROLLMENT SIGNIFICANTLY DECREASES PROSTATE CANCER SCREENING12
IP03-39 BENEFITS OF HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) OVER TRANSURETHRAL RESECTION (TURP) FOR BLADDER OUTLET OBSTRUCTION (BOO) IN PATIENTS WITH PROSTATE CANCER: A PROPENSITY SCORE-MATC12
IP18-06 INFECTION FOLLOWING INFLATABLE PENILE PROSTHESIS PLACEMENT: A REAL-WORLD COMPARISON OF DEVICE SELECTION AND PATIENT CHARACTERISTICS12
PD06-01 INNOVATIVE BIOMARKERS: SERUM ANDROSTENEDIONE AND STEROID RATIOS AS PREDICTORS OF SPERM RETRIEVAL IN NON-OBSTRUCTIVE AZOOSPERMIA12
V10-04 A MODIFIED TECHNIQUE FOR DOUBLE DISTAL CORPORAL ANCHORING STITCH IN THE MANAGEMENT OF LATERAL PENILE PROSTHESIS CYLINDER EXTRUSION12
PD26-11 RENAL MASS BIOPSY FOR SMALL RENAL MASSES: A SINGLE-CENTER 20-YEAR EXPERIENCE12
IP08-28 CLINICAL OUTCOMES COMPARING MINI VERSUS STANDARD TUBELESS PERCUTANEOUS NEPHROLITHOTOMY: A MULTI-INSTITUTIONAL RANDOMIZED CONTROLLED TRIAL FROM THE EDGE CONSORTIUM12
MP26-06 DOES IT REALLY MATTER? OUTCOMES OF SCROTAL EXPLORATION FOR TESTICULAR TORSION PERFORMED BY PEDIATRIC UROLOGISTS VS. ADULT UROLOGISTS12
GG03-16 COMPARATIVE ANALYSIS OF PROSTATE VOLUME MEASUREMENT METHODS FOR PSA DENSITY: DEEP LEARNING-BASED AUTOSEGMENTATION IN MR/TRUS FUSION TARGETED PROSTATE BIOPSY12
IP07-26 CORRELATION BETWEEN MAYO ADHESIVE PROBABILITY SCORE (MAP) AND SURGICAL OUTCOMES IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY12
IP10-18 DOES KIDNEY TRANSPLANTATION IMPROVE ERECTILE FUNCTION? A PROSPECTIVE COHORT ANALYSIS OF END-STAGE RENAL DISEASE PATIENTS PRE AND POST KIDNEY TRANSPLANTATION IN MEXICO12
IP27-24 OSTEOPOROSIS AMONGST TESTICULAR CANCER SURVIVORS: LONG TERM FOLLOW-UP OF THE VETERANS AFFAIRS HEALTH SYSTEM12
MP37-18 IS IT WORTH USING THE COMPREHENSIVE COMPLICATION INDEX OVER THE CLAVIEN-DINDO CLASSIFICATION IN ELDERLY PATIENTS WHO UNDERWENT PERCUTANEOUS NEPHROLITHOTOMY?12
MP14-15 IMPACT OF CYTOREDUCTIVE NEPHRECTOMY AND TIMING OF SYSTEMIC THERAPY ON OVERALL SURVIVAL IN METASTATIC NON-CLEAR CELL RENAL CELL CARCINOMA12
IP20-22 BEYOND THE CONVENTIONAL APPROACH: PREPROCEDURAL CAUDAL VS. POSTPROCEDURAL PENILE BLOCKS FOR PEDIATRIC UROLOGIC SURGERY PAIN MANAGEMENT IN PENILE SURGERIES12
IP10-19 EXPLORING THE PREVALENCE OF POLYCYTHEMIA AMONG MEN IN TESTOSTERONE THERAPY12
IP27-40 CARE EXPERIENCE AND SUPPORT NEEDS OF TESTICULAR CANCER SURVIVORS: A QUALITATIVE STUDY12
IP27-31 EFFICACY OF TRIPLE TRACER TECHNIQUE (TC 99 RADIOCOLLOID, INDOCYANINE GREEN, AND BLUE DYE) VERSUS DUAL DYE TECHNIQUE (INDOCYANINE GREEN, METHYLENE BLUE) FOR SENTINEL NODE BIOPSY IN CLINICALLY N12
PD08-02 LONG-TERM OUTCOMES OF AQUABLATION FOR BENIGN PROSTATIC HYPERPLASIA: WATER, WATER II, OPEN WATER, FRANCAIS WATER, AND JAPAN PMS STUDIES12
V04-08 BREAKING BARRIERS IN ROBOTIC SURGERY: THE EFFICIENCY AND SAFETY OF LOW-COST, SINGLE-PORT EXTRAPERITONEAL SINGLE PORT ROBOTIC ASSISTED RADICAL PROSTATECTOMY12
IP14-07 THERMOSENSITIVE LIPOSOMAL DOXORUBICIN COMBINED WITH HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY FOR TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER12
IP20-02 HOW BLADDER EXSTROPHY AFFECTS MOTHERS' QUALITY OF LIFE, RESILIENCE, AND MENTAL HEALTH: A COMPARISON OF SINGLE-CHILD AND MULTIPLE-CHILD FAMILIES12
IP06-27 ANALYSIS OF GENETIC TESTING IN KIDNEY STONE DISEASE: A SINGLE-INSTITUTIONAL ANALYSIS12
PD38-09 NEDD4-MEDIATED UBIQUITINATION OF GPX4: A KEY PATHWAY IN HIGH GLUCOSE-INDUCED FERROPTOSIS IN CORPUS CAVERNOSUM SMOOTH MUSCLE CELLS12
V10-06 A NOVEL TECHNIQUE FOR DIRECT VISUALIZATION OF INFLATABLE PENILE PROSTHESIS RESERVOIR PLACEMENT USING A SINGLE-INCISION PENOSCROTAL APPROACH12
IP16-40 PATHOLOGIC FINDINGS AMONG RENAL MASSES IN SOLID ORGAN TRANSPLANT PATIENTS11
GG02-28 UTILITY OF FRAILTY IN PREDICTING SEVERE ADVERSE EVENTS IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER TREATED WITH UPFRONT DOCETAXEL OR DAROLUTAMIDE PLUS DOCETAXEL: A MULTICENTER RETROSPECTIV11
IP11-23 URETERAL TISSUE TEMPERATURE WITH HO:YAG LASER ACTIVATION DURING URETEROSCOPY IN AN IN-VIVO PORCINE MODEL11
Our Ongoing Evolution of Peer Review11
IP26-33 THE IMPACT OF ANDROGEN DEPRIVATION THERAPY ON LOWER URINARY TRACT SYMPTOMS IN PROSTATE CANCER PATIENTS11
MP05-08 A NOVEL URODYNAMIC SCORING SYSTEM FOR EVALUATING CONTINENCE QUALITY OUTCOMES OF TOTALLY INTRACORPOREAL ROBOTIC ORTHOTOPIC ILEAL NEOBLADDERS AT MID-TERM FOLLOW-UP: RESULTS OF A PROSPECTIVE MULT11
PD37-07 CONSOLIDATIVE SURGERY FOR ADVANCED UROTHELIAL CARCINOMA FOLLOWING INDUCTION ENFORTUMAB VEDOTIN AND/OR IMMUNE CHECKPOINT INHIBITOR THERAPY: A MULTICENTER ANALYSIS11
IP26-14 THERAPEUTIC TARGETING OF ARHGEF2 -RAC1 SIGNALING FOR NEUROENDOCRINE PROSTATE CANCER11
MP17-20 COMPARISON OF CLINICAL CHARACTERISTICS BETWEEN VON HIPPEL-LINDAU SYNDROME PATIENTS WITH MONOGENIC AND POLYGENIC MUTATIONS: A RETROSPECTIVE ANALYSIS BASED ON NEXT-GENERATION SEQUENCING RESULTS 11
Reply by Authors11
MP23-14 ALTERNATIVE TO EMERGENCY DEPARTMENT FOR THE AFTER-HOURS CARE OF URGENT UROLOGIC ISSUES IN ESTABLISHED PATIENTS11
0.35155701637268